[go: up one dir, main page]

IL90892A0 - Rifapentine hydrohalides - Google Patents

Rifapentine hydrohalides

Info

Publication number
IL90892A0
IL90892A0 IL90892A IL9089289A IL90892A0 IL 90892 A0 IL90892 A0 IL 90892A0 IL 90892 A IL90892 A IL 90892A IL 9089289 A IL9089289 A IL 9089289A IL 90892 A0 IL90892 A0 IL 90892A0
Authority
IL
Israel
Prior art keywords
pct
rifapentine
sec
date
hydrohalides
Prior art date
Application number
IL90892A
Other languages
English (en)
Original Assignee
Lepetit Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit Spa filed Critical Lepetit Spa
Publication of IL90892A0 publication Critical patent/IL90892A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Dental Preparations (AREA)
  • Fats And Perfumes (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Liquid Crystal Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
IL90892A 1988-07-13 1989-07-06 Rifapentine hydrohalides IL90892A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888816620A GB8816620D0 (en) 1988-07-13 1988-07-13 Rifapentine hydrohalides

Publications (1)

Publication Number Publication Date
IL90892A0 true IL90892A0 (en) 1990-02-09

Family

ID=10640347

Family Applications (1)

Application Number Title Priority Date Filing Date
IL90892A IL90892A0 (en) 1988-07-13 1989-07-06 Rifapentine hydrohalides

Country Status (20)

Country Link
US (1) US5306715A (xx)
EP (1) EP0440642B1 (xx)
JP (1) JP2716553B2 (xx)
KR (1) KR0135312B1 (xx)
CN (1) CN1039421A (xx)
AT (1) ATE111101T1 (xx)
AU (1) AU632754B2 (xx)
CA (1) CA1339215C (xx)
DE (1) DE68918107T2 (xx)
DK (1) DK173423B1 (xx)
ES (1) ES2018374A6 (xx)
GB (1) GB8816620D0 (xx)
GR (1) GR1002222B (xx)
HK (1) HK1005455A1 (xx)
HU (1) HU210716A9 (xx)
IE (1) IE65812B1 (xx)
IL (1) IL90892A0 (xx)
PT (1) PT91132B (xx)
WO (1) WO1990000553A1 (xx)
ZA (1) ZA894991B (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI94339C (fi) 1989-07-21 1995-08-25 Warner Lambert Co Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi
DK0536197T3 (da) * 1990-06-29 1995-11-13 Lepetit Spa Ren, krystallinsk form af rifapentine
HRP20000162B1 (en) 2000-03-20 2004-06-30 Pliva D D Amorphous torasemide modification
JP4393098B2 (ja) * 2002-06-21 2010-01-06 独立行政法人科学技術振興機構 アンサマイシン系抗生物質の新規用途及び新規血管新生抑制物質のスクリーニング方法
EP1592668A1 (en) * 2003-02-12 2005-11-09 Ciba SC Holding AG Crystalline forms of pitavastatin calcium
ITMI20032144A1 (it) * 2003-11-07 2005-05-08 Alfa Wassermann Spa Forme polimorfe di rifaximina, processi per ottenerle e
ES2522895T3 (es) * 2005-03-03 2014-11-19 Alfa Wassermann S.P.A. Nuevas formas polimorfas de rifaximina, procedimientos para su producción y uso de las mismas en preparados medicinales
JP2007246514A (ja) * 2006-02-14 2007-09-27 Toyama Chem Co Ltd ピペラシリンナトリウムの新規な結晶
CN101611040A (zh) * 2007-01-31 2009-12-23 富山化学工业株式会社 哌拉西林钠的新颖结晶
IT1398550B1 (it) 2010-03-05 2013-03-01 Alfa Wassermann Spa Formulazioni comprendenti rifaximina utili per ottenere un effetto prolungato nel tempo
CA2861104A1 (en) * 2012-01-25 2013-08-01 Salix Pharmaceuticals, Ltd. Rifaximin derivative and uses thereof
ITBO20120368A1 (it) 2012-07-06 2014-01-07 Alfa Wassermann Spa Composizioni comprendenti rifaximina e amminoacidi, cristalli di rifaximina derivanti da tali composizioni e loro uso.
US20240199642A1 (en) * 2021-04-21 2024-06-20 Interquim S.A. De C.V. Method for obtaining rifapentine with a new crystalline form

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR208F (xx) * 1964-07-31
GB1478563A (en) * 1975-03-05 1977-07-06 Lepetit Spa Rifamycin derivatives
FR2309556A1 (fr) * 1975-04-29 1976-11-26 Aries Robert Aminoguanidines derivees de la rifamycine
US4876258A (en) * 1987-08-13 1989-10-24 Ciba-Geigy Corporation Biphenylyl compounds
KR890701591A (ko) * 1987-09-25 1989-12-21 베르너 발데그 4-(트리알킬벤질)-피페라지닐 화합물의 디아실 유도체

Also Published As

Publication number Publication date
KR900701798A (ko) 1990-12-04
PT91132A (pt) 1990-02-08
DK292590A (da) 1990-12-10
AU632754B2 (en) 1993-01-14
ZA894991B (en) 1990-08-29
GR1002222B (en) 1996-04-17
WO1990000553A1 (en) 1990-01-25
JP2716553B2 (ja) 1998-02-18
DK292590D0 (da) 1990-12-10
HK1005455A1 (en) 1999-01-08
DK173423B1 (da) 2000-10-09
IE65812B1 (en) 1995-11-15
ATE111101T1 (de) 1994-09-15
EP0440642A1 (en) 1991-08-14
KR0135312B1 (ko) 1998-04-23
DE68918107D1 (de) 1994-10-13
DE68918107T2 (de) 1995-01-26
AU3770289A (en) 1990-02-05
JPH03506025A (ja) 1991-12-26
CN1039421A (zh) 1990-02-07
HU210716A9 (en) 1995-06-28
GR890100448A (el) 1990-06-27
CA1339215C (en) 1997-08-05
EP0440642B1 (en) 1994-09-07
GB8816620D0 (en) 1988-08-17
ES2018374A6 (es) 1991-04-01
PT91132B (pt) 1994-12-30
US5306715A (en) 1994-04-26
IE892247L (en) 1990-01-13

Similar Documents

Publication Publication Date Title
GB8816620D0 (en) Rifapentine hydrohalides
AR244193A1 (es) Un procedimiento continuo para preparar 1,1,1-trifluoro-2,2-dicloroetano
IT1230779B (it) Procedimento per preparare 1,1,1,2 tetrafluoroetano.
DE58908138D1 (en) 2,3-difluorbenzole.
DE58905134D1 (en) 2,3-difluorbiphenyle.
IT1215759B (it) Unita' di scorrimento ad ampia registrabilita' per macchine operatrici.
OA09196A (en) "Tétrahydroimidazo (1,4) benzodiazépin-2-thiones antivirales".
CS185984A2 (en) Zpusob vyroby 3 (amino nebo subst.amino) 4 (subst.amino) l,2,5 thiadiazolu
ZA924594B (en) Process for making 1,3,5,7-tetranitro-1,3,5,7-tetraazacyclooctane
ES557075A0 (es) Procedimiento para preparar un derivado de 1,3-oxazolidina-2-ona.
IT1230795B (it) Procedimento per preparare 1,1,1,2 tetrafluoroetano da 1,1 dicloro 1,2,2,2 tetrafluoroetano.
DE68913498D1 (en) 1,1-dioxo-cephem-4-carbothiolsäure-derivate.
GB2226662B (en) Assembly,e.g. for use in a timepiece
EP0425122A3 (en) A process for preparing n,n',bis(tetrabromophthalimide)
ZA932164B (en) Moisturizer.
ES545622A0 (es) Un procedimiento para preparar bisarilamidas de n,n'-di(1 aminoalquil-2) alquilendiaminas.
AR243727A1 (es) 4-alcoxi-n-(2,3-diclorofenil)benzamidas utiles como reguladores del crecimiento de las plantas.
FI906009A7 (fi) Menetelmä des(64,65)-proinsuliinin valmistamiseksi
EP0394467A4 (en) Operation machine link mechanism
EP0630904A4 (en) Novel nicotine derivative.
DE69013332D1 (en) N-(3',4'-dimethoxyzimtsäure)anthranilsäure.
ES554039A0 (es) Un procedimiento para preparar derivados de 3-amino-4-oxo-2,3,4,5-tetrahidro-1,5-benzoxazepina.
AR243152A1 (es) Un procedimiento de obtencion de 1,2-diamino-bencenos 4-sustituidos.
EP0447345A3 (en) New azaspyro (4.5) decane-7,9-dione derivatives
ATE35507T1 (de) Neue 4,5-g(a)epoxymorphinan-6-spiro-2'-(4'karboxy-1',3'-thiazolidin)-abkoemmlinge.